3M India: Rajiv Gupta ceases as Healthcare Business Leader, transitions to new 3M Group role
3M India Limited has formally intimated the cessation of Rajiv Gupta as Country Business Leader - Healthcare Business and Senior Management Personnel effective April 30, 2026, as he transitions to a new role within the 3M Group. This follows the earlier announcement of Jerry Daniel's appointment as the new Country Business Leader - Healthcare effective May 1, 2026. The disclosure was made in compliance with SEBI Listing Regulations.

*this image is generated using AI for illustrative purposes only.
3M India Limited has provided formal intimation regarding the cessation of Rajiv Gupta as Country Business Leader - Healthcare Business and Senior Management Personnel, effective April 30, 2026. This development follows the company's earlier announcement on April 16, 2026, about leadership changes in its healthcare division.
Cessation Details
Rajiv Gupta has formally communicated his decision to step down from his current position, effective from the close of business hours on April 30, 2026. In his resignation letter addressed to the Managing Director, Gupta stated that he will be taking up a new role within the 3M Group, necessitating his cessation as Country Business Leader - Healthcare Business and consequently as Senior Management Personnel of the company.
| Parameter | Details |
|---|---|
| Person: | Rajiv Gupta |
| Position: | Country Business Leader - Healthcare Business |
| Cessation Date: | April 30, 2026 (close of business hours) |
| Reason: | Transition to new role within 3M Group |
| Status: | Cessation as Senior Management Personnel |
Leadership Transition Context
The cessation of Gupta follows the Board of Directors' approval of Jerry Daniel as the new Country Business Leader - Healthcare, effective May 1, 2026. Daniel, currently serving as Business Operations Leader - Transportation & Energy based in Pune, brings over a decade of experience within the 3M organization since 2013.
Regulatory Compliance
The intimation was made in compliance with Regulation 30 read with sub-para 7C of Para A of Part A Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The formal letter submitted by Rajiv Gupta has been enclosed as Annexure A to the regulatory filing.
The disclosure, dated April 23, 2026, was signed by Pratap Rudra Bhuvanagiri, Company Secretary & Compliance Officer, and communicated to both BSE Limited (Scrip Code: 523395) and National Stock Exchange of India Limited (Scrip Code: 3MINDIA). This communication serves as a continuation of the earlier disclosure dated April 16, 2026, regarding Gupta's transition.
Historical Stock Returns for 3M India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.16% | -4.30% | -0.03% | -12.99% | +6.75% | +24.71% |
How might Jerry Daniel's automotive and aerospace background influence 3M India's healthcare business strategy and product development priorities?
What impact could this leadership transition have on 3M India's healthcare market share and competitive positioning in the Indian market?
Will Rajiv Gupta's move to a senior role within the global 3M Group signal potential changes in the company's India operations or regional strategy?


































